source
- CMS proposes changes to curb 340B drug discount program’s costly subsidies to safety-net hospitalsCasey B. Mulligan, chief economist and chief regulatory officer at HHS, wrote an opinion piece outlining a major flaw in the 340B drug discount program. The program, created in 1992, gives steep di…
- NIH funding uncertainty clouds US research, dampens biotech investor sentimentThe latest episode of STAT’s “The Readout LOUD” podcast examined how the National Institutes of Health is allocating its budget and the growing uncertainty surrounding future funding. Hosts Elaine…